Treatment of gastric precancerous lesions with Weiansan

Table 1 Changes of GA in WAS and WFC groups after treatment

Group	Cases (n)	Atrophy improvement			No change	Severe
		0	+	++<-	-
WAS	42	2	22	6	10	2
WFC	34	2	16	8	8	0

0: Have changes but not achieve a state (less than a +); +: Effective; ++<-: Obviously effective.

Table 2 Changes of GED and IM in WAS and WFC groups after treatment

Group	Cases (n)	GED and IM improvement			No change	Severe
		0	+	++<-	-
WAS	20	2	8	2	4	2
WFC	16	0	4	6	4	2

0: Have changes but not achieve a state (less than a +); +: Effective; ++<-: Obviously effective.

Table 3 Curative effect in WAS and WFC groups

Group	Cases (n)	cure	Obviouslyeffective	Effective	Ineffective	Effectiverate (%)
WAS	42	4	20	12	6	85.71
WFC	34	4	12	12	6	82.35

Table 4 H pylori elimination in WAS and WFC groups

oup	Cases (n)	Positive	Negative	Negative rate (%)
WAS	42	6	36	85.74a
WFC	34	13	21	61.71

^aP < 0.05 vs WFC group.

Table 5 H pylori situation in GPL of model and control groups after 12 wk of treatment

Group	Cases (n)	Positive	Negative	Infective rate (%)
Model group	10	9	1	90a
Control group	5	0	5	0

Table 6 H pylori eliminating situation after 12 wk of treatment

Group	Cases (n)	Positive	Negative	Eliminating rate (%)
High-dose WAS group	10	4	6	60
Low-dose WAS group	10	6	4	40
WFC group	10	4	6	60
Model group	10	9	1	10